BELLO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.032
EU - Europa 855
AS - Asia 359
OC - Oceania 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.026
IT - Italia 377
CN - Cina 287
SE - Svezia 142
FI - Finlandia 105
GB - Regno Unito 96
DE - Germania 48
VN - Vietnam 20
HK - Hong Kong 19
UA - Ucraina 18
IE - Irlanda 14
IN - India 13
FR - Francia 12
ES - Italia 8
TR - Turchia 7
PL - Polonia 6
NL - Olanda 5
CA - Canada 4
CH - Svizzera 4
JP - Giappone 4
BE - Belgio 3
PK - Pakistan 3
AT - Austria 2
AU - Australia 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
RU - Federazione Russa 2
SI - Slovenia 2
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
LU - Lussemburgo 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
SG - Singapore 1
TW - Taiwan 1
Totale 7.255
Salva come PNG Salva come JPEG
Città #
Fairfield 1.100
Woodbridge 654
Houston 520
Ashburn 471
Ann Arbor 470
Chandler 461
Seattle 393
Cambridge 362
Wilmington 327
San Diego 148
Princeton 120
Padova 119
Medford 110
Beijing 98
Roxbury 92
Des Moines 86
Jacksonville 73
Helsinki 49
Boardman 44
New York 44
Nanjing 37
London 23
Dong Ket 20
Hong Kong 18
Milan 18
Nanchang 17
Shenyang 16
Dublin 14
Ovada 14
Cagliari 13
Hebei 12
Jinan 12
Norwalk 12
Ogden 12
Rome 12
Guangzhou 10
Changsha 9
Phoenix 9
Prescot 8
Hounslow 7
Bari 6
Hefei 6
Jiaxing 6
Kilburn 6
Naples 6
Shanghai 6
Tianjin 6
Borås 5
Falls Church 5
Ningbo 5
Redwood City 5
Borgosatollo 4
Cadillac 4
Chicago 4
Dearborn 4
Fuscaldo 4
Kunming 4
Las Vegas 4
Pune 4
Rovigo 4
Venice 4
Washington 4
Zhengzhou 4
Azzano San Paolo 3
Detroit 3
Hangzhou 3
Kharkiv 3
Lamezia Terme 3
Legnago 3
Mountain View 3
Palermo 3
Quintanar de la Orden 3
Redmond 3
Rockville 3
Santa Maria La Carita 3
Tappahannock 3
Thiene 3
Yokosuka 3
Anzano del Parco 2
Arcugnano 2
Auckland 2
Bardello 2
Brendola 2
Buffalo 2
Caserta 2
Castellammare di Stabia 2
Chiswick 2
Cluj-Napoca 2
Diyarbakır 2
Fuzhou 2
Grottammare 2
Indiana 2
Karachi 2
Lappeenranta 2
Livorno 2
Los Angeles 2
Mairena del Aljarafe 2
Marano Vicentino 2
Monmouth Junction 2
Montesilvano Marina 2
Totale 6.233
Salva come PNG Salva come JPEG
Nome #
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 177
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 161
Parkinson-like features in ALS with predominant upper motor neuron involvement 145
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 143
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 134
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 130
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 125
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 121
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 114
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 110
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 108
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 107
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 107
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 107
Reliability of the North Star Ambulatory Assessment in a multicentric setting 106
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 104
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 103
Muscle MRI and functional outcome measures in Becker muscular dystrophy 101
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 95
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 94
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study 92
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 92
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 91
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 91
Redefining phenotypes associated with mitochondrial DNA single deletion 91
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 91
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 90
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 90
Pilot trial of clenbuterol in spinal and bulbar muscular atrophy. 89
Functional changes in Duchenne muscular dystrophy A 12-month longitudinal cohort study 88
Molecular bases of phenotypic and clinical variability in Duchenne and Becker muscular dystrophy 88
Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E 87
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages 85
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 85
Revisiting mitochondrial ocular myopathies: a study from the Italian Network 84
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 83
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 82
The clinical spectrum of CASQ1-related myopathy 81
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 80
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 80
Interpreting genetic variants in titin in patients with muscle disorders 79
Dystrophinopathies 78
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 78
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy 78
Genetic modifiers of muscle: Studies of college students and Duchenne muscular dystrophy 76
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 75
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy 74
Muscle MR Imaging in Tubular Aggregate Myopathy. 72
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 71
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data 71
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 69
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study 68
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study 64
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients 61
Cognitive profile in LGMD-2I 61
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 61
Evaluation of peripherin in biofluids of patients with motor neuron diseases 61
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 59
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 59
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A) 58
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis. 57
The "Usual Suspects": Genes for Inflammation, Fibrosis, Regeneration, and Muscle Strength Modify Duchenne Muscular Dystrophy 56
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 56
Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells 55
DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions 53
Whole-Body Muscle Magnetic Resonance Imaging in Glycogen-Storage Disease Type III 50
Genome-Wide Association Studies in Muscle Physiology and Disease 49
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy 48
Myotonic dystrophy type 1. CTG triplet expansion re-tested after 10 years: molecular and clinical considerations 46
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 46
Genetic modifiers of ambulation in the CINRG duchenne natural history study. 45
Mitochondrial disorders of the nuclear genome 45
Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy 45
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 44
Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy 44
Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy 43
Assessment of disease progression in dysferlinopathy: A 1-year cohort study 43
Ablation of collagen VI leads to the release of platelets with altered function 41
A Mutation in the CASQ1 Gene Causes a Vacuolar Myopathy with Accumulation of Sarcoplasmic Reticulum Protein Aggregates. 40
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 40
Caregiver psychological profile and perceived quality of life in children affected by Duchenne Muscular Dystrophy 39
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy 39
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 38
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases 38
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 36
A case of ‘never-experienced before’ headache in a young man. 35
Cognitive and neuroradiological profile in LGMD-2I 35
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale 35
226thENMC International Workshop:. Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands 34
PROCEEDINGS OF THE XXI CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: Digital EditionDecember 01-04, 2021 Neurofilament light chain and Profilin-1 in adult SMA patients under nusinersen treatment: 26-months follow-up 33
Large scale networks for human hand-object interaction: Functionally distinct roles for two premotor regions identified intraoperatively 32
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen 31
Extrapiramidal abnormalities in progressive external opthalmoplegia 30
North Star Ambulatory Assessement, 6-minute walking test and timed items in ambulatory boys with Duchenne muscular dystrophy 29
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 28
Osteopontin in Duchenne muscular dystrophy. 27
Cognitive profile in LGMD-2I 27
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 27
Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways 27
Transient and recurrent CNS involvement in a 21-year-old man affected with CMT1X (Connexin-32). 25
Totale 7.096
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.717
article - articoli 26.193
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 364
Totale 55.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019546 0 0 0 0 0 0 0 0 0 110 232 204
2019/20201.379 169 57 10 103 127 102 157 141 221 129 92 71
2020/20211.227 45 77 46 199 71 58 42 132 144 165 165 83
2021/20221.758 180 174 225 112 64 121 115 158 54 57 150 348
2022/20231.026 222 69 28 116 177 144 7 73 105 25 46 14
2023/2024605 16 70 83 65 60 93 83 57 52 26 0 0
Totale 7.489